185 related articles for article (PubMed ID: 38017409)
1. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
[TBL] [Abstract][Full Text] [Related]
2.
Somsuan K; Peerapen P; Boonmark W; Plumworasawat S; Samol R; Sakulsak N; Thongboonkerd V
FASEB J; 2019 Nov; 33(11):12226-12239. PubMed ID: 31424966
[TBL] [Abstract][Full Text] [Related]
3. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
[TBL] [Abstract][Full Text] [Related]
4. ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity.
Yoodee S; Peerapen P; Plumworasawat S; Thongboonkerd V
Int J Biol Macromol; 2021 Jun; 180():1-13. PubMed ID: 33675830
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
[TBL] [Abstract][Full Text] [Related]
6. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
Hu C; Li W; Tian F; Jiang K; Liu X; Cen J; He Q; Qiu Z; Kienast Y; Wang Z; Zhang H; Ji Y; Hu J; Hui L
J Hepatol; 2018 Mar; 68(3):465-475. PubMed ID: 29113912
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Arid1a deletion disrupts the balance among angiogenesis, neurogenesis and gliogenesis in the developing brain.
Wang Y; Su L; Wang W; Zhao J; Wang Y; Li S; Liu Y; Chai R; Li X; Teng Z; Liu C; Hu B; Ji F; Jiao J
Cell Prolif; 2023 May; 56(5):e13447. PubMed ID: 36916004
[TBL] [Abstract][Full Text] [Related]
8. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of mutated ARID1A inhibited endometrial cancer cell proliferation and stimulated cell apoptosis.
Ye Y; Wei B; Xiaowei X
J BUON; 2018; 23(4):1082-1091. PubMed ID: 30358215
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.
Guan B; Gao M; Wu CH; Wang TL; Shih IeM
Neoplasia; 2012 Oct; 14(10):986-93. PubMed ID: 23097632
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of the ARID1A tumor suppressor.
Luo Q; Wu X; Liu Z
Cancer Lett; 2020 Oct; 491():1-10. PubMed ID: 32738271
[TBL] [Abstract][Full Text] [Related]
13. METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.
Lee SA; Lee KH; Kim H; Cho JY
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063990
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
Kimura A; Arakawa N; Hirano H
J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.
Stubbs FE; Flynn BP; Rivers CA; Birnie MT; Herman A; Swinstead EE; Baek S; Fang H; Temple J; Carroll JS; Hager GL; Lightman SL; Conway-Campbell BL
Oncogene; 2022 Dec; 41(50):5347-5360. PubMed ID: 36344675
[TBL] [Abstract][Full Text] [Related]
17. ARID1B is a specific vulnerability in ARID1A-mutant cancers.
Helming KC; Wang X; Wilson BG; Vazquez F; Haswell JR; Manchester HE; Kim Y; Kryukov GV; Ghandi M; Aguirre AJ; Jagani Z; Wang Z; Garraway LA; Hahn WC; Roberts CW
Nat Med; 2014 Mar; 20(3):251-4. PubMed ID: 24562383
[TBL] [Abstract][Full Text] [Related]
18. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
Guan B; Wang TL; Shih IeM
Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
[TBL] [Abstract][Full Text] [Related]
19. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
[TBL] [Abstract][Full Text] [Related]
20. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]